Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board
Eterna Therapeutics Inc - a Cambridge, Massachusetts life science company dedicated to mRNA cell engineering to create new medicines – has appointed Jeff Karp, Ph.D. to Eterna’s Scientific Advisory Board.
Dr. Karp is the Distinguished Chair in Clinical Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School in Boston.
He is also a principal faculty member at the Harvard Stem Cell Institute, and an affiliate faculty member at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.
Dr. Karp was elected a fellow of the National Academy of Inventors, Royal Society of Chemistry, American Institute for Medical and Biological Engineering’s College of Fellows, Biomedical Engineering Society (BMES), and the Canadian Academy of Engineering.
He has published over 125 peer-reviewed papers with more than 30,000 citations. Several technologies developed in his lab have led to multiple products currently in development or on the market, and to the launch of ten companies.
Dr. Karp has received more than 50 awards and honors. Most recently, he received the Clemson Award for Applied Research, the highest award for innovation from the Society for Biomaterials. Boston Magazine recognized Dr. Karp as one of 11 Boston Doctors Making Medical Breakthroughs and the Boston Business Journal recognized him as a Champion in Healthcare Innovation. MIT Technology Review magazine also recognized Dr. Karp as being one of the top innovators in the world in its “TR35” list, and three members from his laboratory have subsequently received this award. His work has been selected by Popular Mechanics as one of the Top 20 New Biotech Breakthroughs that Will Change Medicine.
Eterna has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system from Factor Bioscience. NoveSlice, UltraSlice, and ToRNAdo are trademarks of Factor Bioscience.
